Mechanism of action of voltage sensitive sodium channel modulators

Journal of Clinical Psychiatry

Volumn 65, Issue 7, 2004, Pages 894-

  Stahl, Stephen M ^a,b  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; NEUROLEPTIC AGENT; SODIUM CHANNEL;

ARTICLE; CHEMICAL MODEL; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; HUMAN; NEURALGIA; SCHIZOPHRENIA; STRUCTURE ACTIVITY RELATION;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; MODELS, CHEMICAL; NEURALGIA; SCHIZOPHRENIA; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 4444335655     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0701     Document Type: Short Survey

References (4)

1. Yu FH, Catterall WA. Overview of the voltage-gated sodium channel family. Genome Biology 2003;4:207.1-207.5 (Pubitemid 36546590)
2. Stahl SM. Psychopharmacology of anticonvulsants: do all anticonvulsants have the same mechanism of action? [BRAINSTORMS] J Clin Psychiatry 2004;65:149-150
3. Stahl SM. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels [BRAINSTORMS]. J Clin Psychiatry 2004;65:738-739
4. Stahl SM. Anticonvulsants and the relief of chronic pain: pregabalin and gabapentin as alpha 2 delta ligands at voltage-gated calcium channels [BRAINSTORMS]. J Clin Psychiatry 2004;65:596-597